Purpose Pathological parameters assessed on biopsies and resection specimens have a
pivotal role in the diagnosis, prognosis and management of patients with renal cell …

Papillary renal cell carcinoma (PRCC) is the second most common type of renal carcinoma
following clear cell renal cell carcinoma. Papillary renal cell carcinoma is usually divided …

Abstract The Genitourinary Pathology Society (GUPS) reviewed recent advances in renal
neoplasia, particularly post-2016 World Health Organization (WHO) classification, to provide …

Renal tumours include a heterogeneous and diverse spectrum of neoplasms. Recent
advances in this field have significantly improved our understanding of the morphological …

Purpose: Fumarate hydratase–deficient renal cell carcinoma (FH-RCC) is a rare, aggressive
form of RCC associated with hereditary leiomyomatosis and RCC syndrome. Evidence for …

Renal cell carcinoma (RCC) subtypes are increasingly being discerned via their molecular
underpinnings. Frequently this can be correlated to histologic and immunohistochemical …

Germline or somatic loss-of-function mutations of fumarate hydratase (FH) predispose
patients to an aggressive form of renal cell carcinoma (RCC). Since other than tumor …

Fumarate hydratase-deficient renal cell carcinoma (FH-deficient RCC) is a rare and recently
described entity associated with hereditary leiomyomatosis and RCC syndrome. FH …

Summary The World Health Organization (WHO) 2022 classification of urinary and male
genital tumours (5th edition) has significantly improved our understanding of the …

In 1952, renal cell carcinomas had been divided into 2 categories—clear cell or granular cell—
depending upon their cytoplasmic staining characteristics. In the following years, the …